⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
globenewswire.com
ATYR
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com
ATYR
Securities Lawsuit Alert: aTyr Pharma, Inc. (ATYR) Investors - Contact Levi & Korsinsky Before December 8, 2025
accessnewswire.com
ATYR
ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Announces that aTyr Pharma Investors Have Opportunity to Lead Class Action Lawsuit
newsfilecorp.com
ATYR
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
ATYR
Pomerantz LLP Reminds Shareholders with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit – ATYR
accessnewswire.com
ATYR
ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATYR
aTyr Pharma (ATYR) Securities Class Action Pending Over Key Drug's Efficacy -- Hagens Berman
prnewswire.com
ATYR
ATYR Deadline: ATYR Investors with Losses in Excess of $100K Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
prnewswire.com
ATYR